Healthcare Author: EqualOcean News, Zhiqing Chen Apr 30, 2021 02:07 AM (GMT+8)

On April 27, Yunnan Baiyao released a report for the first quarter of 2021 showing that the company's total operating revenue for the first quarter was 10.33 billion yuan, up 33.4% year-on-year; its operating profit was 880 million yuan, down 41.8% year-on-year; its net profit attributable to shareholders of the listed company was 760 million yuan.

yunnan baiyao

  • On April 28, Yunnan Baiyao's share price closed down 2.62% to CNY 111.99, with a market value of CNY 143.1 billion.

  • The decline in net profit in the first quarter was mainly due to the impact of gains and losses from changes in the fair value of securities investments. 

  • The company's investment holdings in two stocks, Xiaomi Group and Yili, lost CNY 690 million and CNY 110 million in the first quarter.

  • In the first quarter of this year, Yunnan Baiyao's total operating costs were CNY 8.58 billion, of which selling expenses were CNY 950 million, accounting for 11.1% of total costs; management expenses were CNY 127 million, accounting for 1.5%; and R&D expenses were CNY 53 million, accounting for 0.6%.

  • In 2020, Yunnan Baiyao's total annual revenue was CNY 32.742 billion, up 10.38% year-on-year; net profit attributable to shareholders of listed companies was CNY 5.516 billion, up 31.85% year-on-year. 

  • Among them, the gain or loss from fair value changes and investment income from holding financial assets for trading and other similar purposes was CNY 2.62 billion, which accounted for almost half of the company's annual net profit.

  • In recent years, Yunnan Baiyao pharmaceutical medicines ranked first in the orthopedic industry, with a market share of 22%. 

  • From 2017 to 2019, the company's revenue was CNY 24.499 billion, CNY 27.017 billion and CNY 29.666 billion, with growth rates of 8.5%, 9.84% and 9.8%, respectively. 

  • On April 28, the company's market capitalization reached CNY 143.06 billion.

Founded in May 1993, Yunnan Baiyao Group has four business segments, including pharmaceuticals, health products, traditional Chinese medicine and provincial medicine. The company has also expanded its business segments to various fields such as medical beauty, orthopedics and rehabilitation equipment. Its product line contains a wide variety of applications, including toothpaste, skincare, hair care and sanitary napkins.